Current position:
Neurologist (MD), working in the Movement Disorders unit of the Pitié-Salpêtrière Hospital.
Scientific expertise:
Physiology and pathophysiology of motor control of movement disorders (dystonia, Parkinson’s disease, essential tremor), Deep Brain Stimulation, Focused Ultrasound, Oculomotorphysiology.
Professional experience
2017-now: Hospital Practitioner in Neurology and Neurophysiology – Pitié- Salpêtrière Hospital, Paris
2013-2017: Hospital Practitioner in Neurophysiology – Saint-Antoine Hospital, Paris
2012-2013: Former Chief Resident of Neurophysiology – Saint-Antoine Hospital, Paris
2008-2011: Former Chief Resident of Neurology – Saint- Antoine Hospital, Paris
2004-2008: Neurology Resident
Contact:
APHP - Movement Disorders Unit
Tel : +33 1 42 16 2461 (Secrétariat)
Institut du Cerveau et de la Moelle épinière
47 bd de l’Hôpital,75013 Paris, France
Tel : +33 1 57 27 4368
Education
2016: PhD in Neuroscience, Pierre Marie Curie University (Paris 6)
2012 : Master in Neuroscience, Pierre Marie Curie University (Paris 6)
2008: MD, Caen University
Scientific societies
Société Française de Neurologie
Société Francophone des Mouvements Anormaux
- Meira B, Degos B, Corsetti E, Doulazmi M, Berthelot E, Virbel-FleischmanC, Dodet P, Méneret A, Mariani LL, Delorme C, Cormier-Dequaire F, BendetowiczD, Villain N, Tarrano C, Mantisi L, Letrillart H, Louapre C, McGovern E, WorbeY, Grabli D, Vidailhet M, Hainque E*, Roze E*. Long-term effect of apomorphine infusion in advancedParkinson's disease: a real-life study. NPJ Parkinsons Dis. 2021 Jun 11;7(1):50. doi: 10.1038/s41531-021-00194-7.
- Santin MDN, Voulleminot P, Vrillon A, Hainque E, Béreau M, Lagha-Boukbiza O, WirthT, Montaut S, Bardinet E, Kyheng M, Rolland AS, Voirin J, Drapier S, Durif F,Eusebio A, Giordana C, Auzou N, Houeto JL, Hubsch C, Jarraya B, Laurencin C,Maltete D, Meyer M, Rascol O, Rouaud T, Tir M, Moreau C, Corvol JC, Proust F,Grabli D, Devos D, Tranchant C, Anheim M; Predistim Study Group. Impact ofSubthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson'sDisease: A Prospective Study. Mov Disord. 2020 Oct 6. doi:10.1002/mds.28320.
- Gallea C, Wicki B, EwenczykC, Rivaud-Péchoux S, Yahia-Cherif L, Pouget P, Vidailhet M, Hainque E.Antisaccade, a predictive marker for freezing of gait in Parkinson's diseaseand gait/gaze network connectivity. Brain. 2020 Dec 6:awaa407. doi:10.1093/brain/awaa407.
- Delorme C, Roze E, Karachi C, Vidailhet M, Hainque E. Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation. Eur JNeurol. 2020 Oct 21. doi: 10.1111/ene.14602.
- Hainque E, Grabli D. Rapid worsening in Parkinson's disease may hide COVID-19 infection. ParkinsonismRelat Disord. 2020 Jun;75:126-127
- Hainque E, Meneret A, Gras D, Atencio M, Luton MP, Barbier M, De Saint Martin A, Billettede Villemeur T, Ottolenghi C, Roze E, Mochel F. Transition from ketogenic dietto triheptanoin in patients with GLUT1 deficiency syndrome. J NeurolNeurosurg Psychiatry. 2020 Apr;91(4):444-445
- Hainque E, Gras D, Meneret A, Atencio M, Luton MP, Barbier M, Doulazmi M, Habarou F,Ottolenghi C, Roze E, Mochel F. Long-term follow-up in an open-label trial oftriheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect. JNeurol Neurosurg Psychiatry. 2019 Apr 4. pii:jnnp-2018-320283. doi: 10.1136/jnnp-2018-320283.
Coming soon!
Coming soon!
